N-Nitrosamines are a group of carcinogens which occur widely in the environment, food, beverages, and tobacco products, and can also be produced endogenously. Metabolic activation is an essential step for these compounds to exert their toxic and carcinogenic actions. It is also a key factor in determining the remarkable organ specificity and species variability of their carcinogenic actions. We have made substantial progress in elucidating the enzymatic basis for the activation of nitrosamines. We plan to continue this successful line of research and to pursue in-depth studies using the following approaches: 1. To elucidate the mechanisms of activation and possible detoxification pathways of N-nitrosodimethylamine and other nitrosamines by studying (a) detailed kinetic parameters, (b) role of cytochrome b5, (c) structure-reactivity relationship, (d) kinetic isotope effect, (e) role of cell integrity, and (f) involvement of oxygen radicals. 2. To study the metabolism of selected nitrosamines by different types of microsomes, purified cytochrome P-450 isozymes, and isolated cells.
The aim i s to understand the molecular basis for the tissue and species variabiltiy, as well as the modulation, of nitrosamine metabolism. 3. To study the metabolism of nitrosamines by human tissue samples and to understand the enzymatic basis for the metabolism. 4. To delineate the relationship between the metabolism of nitrosamines and their activation to mutagens for V79 cells as well as to examine the genotoxic damage involved. The studies will yield precise information on the enzyme specificity and mechanisms of the activation of nitrosamines. Such information is important to the understanding of nitrosamine carcinogenesis in animals and humans. This knowledge will be useful in designing potential means for cancer prevention.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Method to Extend Research in Time (MERIT) Award (R37)
Project #
Application #
Study Section
Special Emphasis Panel (NSS)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Rutgers University
Schools of Pharmacy
New Brunswick
United States
Zip Code
Smith, T J; Liao, A; Wang, L D et al. (1998) Characterization of xenobiotic-metabolizing enzymes and nitrosamine metabolism in the human esophagus. Carcinogenesis 19:667-72
Smith, T J; Guo, Z; Guengerich, F P et al. (1996) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate. Carcinogenesis 17:809-13
Ardies, C M; Smith, T J; Kim, S et al. (1996) Induction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) activation in rat lung microsomes by chronic ethanol consumption and repeated running exercise. Cancer Lett 103:209-18
Wang, L D; Zhou, Q; Hong, J Y et al. (1996) p53 protein accumulation and gene mutations in multifocal esophageal precancerous lesions from symptom free subjects in a high incidence area for esophageal carcinoma in Henan, China. Cancer 77:1244-9
Smith, T J; Hong, J Y; Wang, Z Y et al. (1995) How can carcinogenesis be inhibited? Ann N Y Acad Sci 768:82-90
Smith, T J; Stoner, G D; Yang, C S (1995) Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides. Cancer Res 55:5566-73
Yang, C S; Smith, T J; Hong, J Y (1994) Cytochrome P-450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations. Cancer Res 54:1982s-1986s
Wang, L D; Shi, S T; Zhou, Q et al. (1994) Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. Int J Cancer 59:514-9
Gao, H; Wang, L D; Zhou, Q et al. (1994) p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China. Cancer Res 54:4342-6
Wang, L D; Hong, J Y; Qiu, S L et al. (1993) Accumulation of p53 protein in human esophageal precancerous lesions: a possible early biomarker for carcinogenesis. Cancer Res 53:1783-7

Showing the most recent 10 out of 60 publications